In other countries
The same active substances on other registers, the same brand first.
- GivlaariBrazil · Specialty Pharma Goias LtdaSame brand
- Givlaari 189 MG/ML Solucion InyectableSpain · 200 mg/ml · solución inyectable · Alnylam Netherlands B.V.Same brand
- GivlaariEuropean Union · Alnylam Netherlands B.V.Same brand
- GivlaariCroatiaSame brand
- GivlaariItaly · Soluzione iniettabile · Alnylam Netherlands BVSame brand
- Givlaari 189 mg/ml oplossing voor injectieNetherlands · Oplossing voor injectie · Alnylam Netherlands B.V.Same brand
- Givlaari Solution for InjectionTaiwan · 注射液劑 · 艾拉倫股份有限公司Same brand
- GivlaariUnited States · 189MG BASE/ML · solution · Alnylam Pharms INCSame brand
Documents
The official texts, at the regulator.
Sources and licences
Compiled by Prognia from the public register below; the register’s text is the official one.
Health Canada, Canada
Health Canada, Drug Product Database, drugproduct API, entire response observed 2026-10-10T15:12:07.336870+00:00; native facts projected by Prognia.
Licence: Open Government Licence Canada · Added 13 Oct 2026
Report an error or request removalCorrections from the holder or the register are welcome.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Active substance
- Givosiran
- Strength
- 189 MG / ML
- Dosage form
- Solution
- Route
- Subcutaneous
- Register
- Canada (Health Canada)
- Status
- Marketed
- Authorised
- 1 Dec 2020
- Registration
- DIN 02506343
- Marketing authorisation holder
- Alnylam Netherlands B.V.
- ATC code
- A16AX16
- Supply
- PRESCRIPTION